Komori
KYORIN Pharmaceutical (4569) · TargetAchieved

Executing “HOPE100 – Stage 2 –”

First written in FY2017-Q1. 12 of 14 entries say "Restated". Latest entry: FY2020.

14entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q1 – FY2020-Q32016: 220162017: 320172018: 420182019: 320192020: 22020
Same theme, other companies

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2020AchievedAnnual report

    「We divided the period from FY2010 through FY2023 into three stages and launched the medium-term management plan “HOPE100-Stage 3-(FY2020–FY2023)” in FY2020 as the final phase of the long-term vision.」

    Stage 2, covering FY2016–FY2019, ended and the Group moved to Stage 3, the final phase, in FY2020. The numerical targets for Stage 2 were not achieved.
  2. FY2020-Q3RestatedAnnual report

    「This fiscal year is the final year of the medium-term management plan “HOPE100-Stage 2-(FY2016–FY2019).”」

    The Group reaffirms that Stage 2 covers FY2016 through FY2019 and that this is its final year.
  3. FY2020-Q1RestatedAnnual report

    「This fiscal year is the final year of the medium-term management plan “HOPE100-Stage 2-(FY2016–FY2019).”」

    The Group continues to execute Stage 2 as a plan covering FY2016 through FY2019 and identifies this fiscal year as its final year.
  4. FY2019RestatedAnnual report

    「The Group is currently working to achieve sustainable growth and enhance corporate value over the medium to long term under the medium-term management plan “HOPE100-Stage 2-(FY2016–FY2019).”」

    Stage 2 continues as the medium-term plan covering FY2016 through FY2019.
  5. FY2019-Q3RestatedAnnual report

    「Under the medium-term management plan “HOPE100-Stage 2-(FY2016–FY2019),” the Group set “Implementing rapid transformation” as its management policy for FY2018.」

    The Group continues to execute Stage 2 as its medium-term plan for FY2016 through FY2019.
  6. FY2019-Q2RestatedAnnual report

    「Under the medium-term management plan “HOPE100-Stage 2-(FY2016–FY2019),” which began in FY2016.」

    The Group continues to execute Stage 2 as its medium-term plan for FY2016 through FY2019.
  7. FY2019-Q1RestatedAnnual report

    「There are no changes to the business strategies or numerical targets for the medium-term management plan “HOPE100-Stage 2-.”」

    The Group expressly states that the business strategies and numerical targets for Stage 2 remain unchanged.
  8. FY2018RestatedAnnual report

    「The Group is currently working to achieve sustainable growth and enhance corporate value over the medium to long term under the medium-term management plan “HOPE100-Stage 2-(FY2016–FY2019).”」

    The Group continues to execute Stage 2 as its medium-term plan for FY2016 through FY2019.
  9. FY2018-Q3RestatedAnnual report

    「Under the medium-term management plan “HOPE100-Stage 2-(FY2016–FY2019),” which began in FY2016.」

    The Group continues to execute Stage 2 for FY2016 through FY2019.
  10. FY2018-Q2RestatedAnnual report

    「Under the medium-term management plan “HOPE100-Stage 2-(FY2016–FY2019),” which began in FY2016.」

    The Group continues to execute Stage 2 as its medium-term plan for FY2016 through FY2019.
  11. FY2017RestatedAnnual report

    「During the fiscal year under review, we formulated and launched the four-year medium-term management plan “HOPE100-Stage 2-,” positioned as the second step toward achieving the long-term vision.」

    Stage 2 continues as a four-year plan.
  12. FY2017-Q3RestatedAnnual report

    「Under the new medium-term management plan “HOPE100-Stage 2-(FY2016–FY2019),” which began this fiscal year.」

    The Group continues to execute the medium-term management plan covering FY2016 through FY2019.
  13. FY2017-Q2RestatedAnnual report

    「Under the new medium-term management plan, “HOPE100 – Stage 2 – (FY2016–FY2019),”」

    The Group continues to execute the medium-term management plan covering FY2016 through FY2019.
  14. FY2017-Q1First statedAnnual report

    「The new medium-term management plan, “HOPE100 – Stage 2 – (FY2016–FY2019),” launched this fiscal year.」

    The new medium-term management plan covering FY2016 through FY2019 was launched.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for KYORIN Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.